H.R. 7418 — Introduced in House

I 118th CONGRESS 2d Session H. R. 7418 IN THE HOUSE OF REPRESENTATIVES February 20, 2024Mr. Kelly of Pennsylvania (for himself and Ms. Houlahan) introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. 1. Exclusion of compensation provided to participants in clinical trials (a) In general Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section: 139J. Clinical trial payments (a) In general Gross income shall not include any amount received by an individual as a qualified clinical trial payment. (b) Qualified clinical trial payment defined For purposes of this section, the term qualified clinical trial payment means any amount paid to an individual— (1) as compensation for participation by the individual or a dependent of the individual in an approved clinical trial, or (2) to reimburse or pay reasonable and necessary expenses incurred in connection with participation by the individual or a dependent of the individual in an approved clinical trial. (c) Other definitions For purposes of this section— (1) Approved clinical trial The term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)), determined by applying disease or condition for life-threatening disease or condition. (2) Dependent The term dependent has the meaning given such term in section 152. . (b) Clerical amendment The table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139I the following new item: Sec. 139J. Clinical trial payments. . (c) Effective date The amendment made by this section shall apply to amounts paid after December 31, 2023.